UY28746A1 - Moduladores de receptores de androgenos - Google Patents

Moduladores de receptores de androgenos

Info

Publication number
UY28746A1
UY28746A1 UY28746A UY28746A UY28746A1 UY 28746 A1 UY28746 A1 UY 28746A1 UY 28746 A UY28746 A UY 28746A UY 28746 A UY28746 A UY 28746A UY 28746 A1 UY28746 A1 UY 28746A1
Authority
UY
Uruguay
Prior art keywords
androgen
receiver modulators
modulators
androgen receiver
benzonitriles
Prior art date
Application number
UY28746A
Other languages
English (en)
Inventor
Lain-Yen Hu
Huangshu Lei
Daniel Yunlong-Du
Bruce Allen Lefker
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of UY28746A1 publication Critical patent/UY28746A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a una nueva clase de 4-oxo-benzonitrilos, a su uso como moduladores de andrógenos y a su uso en el tratamiento de la alopecia.
UY28746A 2004-02-13 2005-02-11 Moduladores de receptores de androgenos UY28746A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54473804P 2004-02-13 2004-02-13
US60564704P 2004-08-30 2004-08-30

Publications (1)

Publication Number Publication Date
UY28746A1 true UY28746A1 (es) 2005-09-30

Family

ID=34890476

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28746A UY28746A1 (es) 2004-02-13 2005-02-11 Moduladores de receptores de androgenos

Country Status (20)

Country Link
US (1) US7576128B2 (es)
EP (1) EP1716110A1 (es)
JP (1) JP3997255B2 (es)
KR (1) KR100783255B1 (es)
AP (1) AP2006003700A0 (es)
AR (1) AR047606A1 (es)
AU (1) AU2005214167B2 (es)
BR (1) BRPI0507670A (es)
CA (1) CA2554696C (es)
CR (1) CR8555A (es)
EA (1) EA009902B1 (es)
EC (1) ECSP066761A (es)
IL (1) IL176935A0 (es)
MA (1) MA28361A1 (es)
NO (1) NO20064053L (es)
PA (1) PA8623501A1 (es)
PE (1) PE20051168A1 (es)
TW (1) TW200534842A (es)
UY (1) UY28746A1 (es)
WO (1) WO2005080320A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1737813A1 (en) 2004-04-13 2007-01-03 Warner-Lambert Company LLC Androgen modulators
CA2562672C (en) 2004-04-22 2009-09-29 Warner-Lambert Company Llc 4-cyano-phenoxy derivatives as androgen modulators
JP4874965B2 (ja) * 2004-07-08 2012-02-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アンドロゲン調節剤
BRPI0514469A (pt) * 2004-08-18 2008-06-10 Warner Lambert Co moduladores de androgênio
KR20070049238A (ko) * 2004-08-31 2007-05-10 워너-램버트 캄파니 엘엘씨 안드로겐 조절제
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
TW200708499A (en) * 2005-06-22 2007-03-01 Warner Lambert Co Process for producing ethers
WO2007007149A1 (en) * 2005-07-12 2007-01-18 Warner-Lambert Company Llc Androgen modulators
US20090170886A1 (en) * 2005-08-08 2009-07-02 Pfizer Inc Androgen modulators
EP3108879A1 (en) * 2015-06-25 2016-12-28 Cassiopea S.p.A. High concentration formulation
EP3833343B1 (en) 2018-08-07 2024-02-21 Emory University Heterocyclic flavone derivatives, compositions, and methods related thereto

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE298470C (es)
US6124343A (en) * 1919-01-27 2000-09-26 Rhone-Poulenc Rorer Limited Substituted phenyl compounds with a substituent having a thienyl ring
US3535365A (en) * 1967-11-29 1970-10-20 Merck & Co Inc Preparation of 2,6-dichloro-4-methoxy-benzonitrile
DE2062349A1 (de) 1970-12-18 1972-06-29 Farbenfabriken Bayer Ag, 5090 Leverkusen Aminoaryloxy-ary!carbonsäurenitrile und ein Verfahren zu ihrer Herstellung
SU469247A3 (ru) 1972-01-14 1975-04-30 Майлз Лабораториз Инк (Фирма) Способ получени производных хромона
US4029493A (en) 1973-02-23 1977-06-14 Mobil Oil Corporation Substituted phenoxybenzonitriles as herbicides
AT330150B (de) * 1973-02-28 1976-06-10 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
FR2397387A1 (fr) * 1976-04-27 1979-02-09 Serobiologiques Lab Sa 4,4'-bis-formyl-polyhalo-diphenoxyalcanes, procede de preparation et application a la synthese de 4,4'-dicyano-polyhalo-diphenoxyalcanes
US4234595A (en) * 1977-07-13 1980-11-18 Mead Johnson & Company 3-Indolyl-tertiary butylaminopropanols
EP0002309B1 (en) 1977-10-12 1982-12-01 Imperial Chemical Industries Plc Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them
DD150456A5 (de) 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
US4567201A (en) 1981-11-25 1986-01-28 Takeda Chemical Industries, Ltd. Diphenoxypropane derivatives and compositions of antiasthmatic and antiinflammatory agents thereof
GB8504093D0 (en) 1985-02-18 1985-03-20 Ici Plc Alkene alkyne/cycloalkylene derivatives
ATE28864T1 (de) 1982-07-23 1987-08-15 Ici Plc Amide-derivate.
EP0107759B1 (de) 1982-08-26 1992-12-16 MERCK PATENT GmbH Cyclohexanderivate und ihre Verwendung als Komponenten Flüssigkristalliner-Dielektrika
JPS59144747A (ja) 1983-02-04 1984-08-18 Chisso Corp ２−クロロ−４−アルキルオキシベンゾニトリル化合物
US4536321A (en) 1983-02-18 1985-08-20 Chisso Corporation Fluorobenzene derivatives and liquid crystal compositions containing the same
DE3515633A1 (de) 1985-05-02 1986-11-06 Merck Patent Gmbh, 6100 Darmstadt Benzonitrile
PH23700A (en) 1985-10-01 1989-09-27 Ciba Geigy Ag Microbicides
EP0269383A3 (en) 1986-11-21 1990-05-02 A.H. Robins Company, Incorporated 1-Aryloxy-4-[(4-aryl)-1-piperazinyl]-2-butanols useful as antiallergy agents
JPS63227502A (ja) 1987-03-17 1988-09-21 Sds Biotech Kk 防菌防カビ剤
US4992433A (en) * 1987-11-23 1991-02-12 Janssen Pharmaceutica N.V. Novel pyridazinamine derivatives
US4925590A (en) * 1988-03-10 1990-05-15 Merck Patent Gesellschaft Mit Beschrankter Haftung Derivatives of 4-cyano-2,3-difluorophenol
DE3825170A1 (de) 1988-07-23 1990-01-25 Hoechst Ag Substituierte 5-(4-(4,5-dihydro-2-oxazolyl)-phenoxyalkylenoxyalkyl)-isoxazole, verfahren sowie 5-(phenoxyalkylenoxyalkyl)-isoxazole als zwischenprodukte zu ihrer herstellung und ihre verwendung zur bekaempfung von krankheiten, die durch infektion mit viren hervorgerufen wurden
JPH03141264A (ja) 1989-08-10 1991-06-17 Glaxo Inc 強心活性およびベータ遮断活性を有するピリダジノン
US5051431A (en) 1989-09-22 1991-09-24 Glaxo Inc. Pyridone nitriles useful in treating cardiovascular disease
DE4017019A1 (de) 1990-05-26 1991-11-28 Hoechst Ag Verwendung von substituierten ss-hydroxyethylaminen als potente hemmstoffe der exoenzyme von pilzen
JPH04124183A (ja) 1990-09-14 1992-04-24 Mitsubishi Rayon Co Ltd 光学活性パントラクトン誘導体
GB9025828D0 (en) 1990-11-28 1991-01-09 Shell Int Research Herbicidal carboxamide derivatives
JP3088777B2 (ja) 1991-03-27 2000-09-18 富士薬品工業株式会社 新規光学分割剤及びそれを用いる光学活性アミンの製造方法
US5320825A (en) 1991-05-01 1994-06-14 Trustees Of The University Of Pennsylvania Serotonin reuptake inhibitors for S.P.E.C.T. imaging
JP3151929B2 (ja) 1992-05-15 2001-04-03 大日本インキ化学工業株式会社 フルオロシクロヘキセン誘導体
DE4217928A1 (de) 1992-05-30 1993-12-02 Hoechst Ag Neue Mischungen aus Herbiziden und Antidots, neue (Hetero-)Aryloxy-Verbindungen, Verfahren zu deren Herstellung, diese enthaltenden Mittel und deren Verwendung
JPH0641038A (ja) 1992-07-17 1994-02-15 Mitsubishi Kasei Corp カルボン酸誘導体
WO1994005153A1 (en) 1992-09-09 1994-03-17 E.I. Du Pont De Nemours And Company Herbicidal benzene compounds
US5455274A (en) 1992-12-09 1995-10-03 Ciba-Geigy Corporation Hydroxyamidine derivatives
US5316755A (en) * 1993-02-02 1994-05-31 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
US5326553A (en) 1993-02-02 1994-07-05 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract
GB2278054A (en) 1993-05-18 1994-11-23 Zeneca Ltd Compounds for the treatment of urinary incontinence
GB9321162D0 (en) 1993-10-13 1993-12-01 Boots Co Plc Therapeutic agents
DE4339863A1 (de) 1993-11-23 1995-05-24 Bayer Ag Substituierte Carbamoyltriazole
TW262553B (es) 1994-03-17 1995-11-11 Hitachi Seisakusyo Kk
AU1897795A (en) 1994-04-21 1995-11-16 Nycomed Imaging As X-ray contrast compositions containing pharmaceutically acceptable clays
JPH07309850A (ja) 1994-05-16 1995-11-28 Canon Inc 光学活性化合物、それを含有する液晶組成物、それを有する液晶素子及びそれらを用いた表示方法、表示装置
EP0684235A1 (en) 1994-05-27 1995-11-29 Mochida Pharmaceutical Co., Ltd. Novel azolyl methyl phenyl derivatives having aromatase inhibitory activity
ES2169102T3 (es) 1994-10-14 2002-07-01 Merck Patent Gmbh (r)-(-)-2-(5-(4-fluorfenil)-3-piridilmetilaminometil)-cromano como agente activo sobre el sistema nervioso central.
JP3802581B2 (ja) 1995-03-01 2006-07-26 富山化学工業株式会社 新規なビフェニル誘導体またはその塩およびそれらを含有する抗炎症剤
JPH08325154A (ja) 1995-03-31 1996-12-10 Mitsui Toatsu Chem Inc 安息香酸誘導体およびそれを有効成分として含有するホスホリパーゼａ２阻害剤
DE19534209A1 (de) * 1995-09-15 1997-03-20 Jenapharm Gmbh Hormonales Mittel zur Behandlung der Haut
US5843983A (en) 1996-02-15 1998-12-01 Sankyo Company, Limited Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use
ES2127106B1 (es) 1996-03-21 1999-11-16 Menarini Lab Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos.
DE19612032A1 (de) 1996-03-27 1997-10-09 Basf Ag Substituierte 1-Methyl-3-benzyluracile
JPH107647A (ja) 1996-06-25 1998-01-13 Yamanouchi Pharmaceut Co Ltd 新規なチオ尿素誘導体又はその塩
US5847166A (en) 1996-10-10 1998-12-08 Massachusetts Institute Of Technology Synthesis of aryl ethers
US6071957A (en) 1996-11-27 2000-06-06 The University Of Tennessee Research Corporation Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
EP1019384A1 (en) 1997-02-04 2000-07-19 Dong Wha Pharmaceutical Industrial Co. Ltd. 3-amino-1,2-benzoisoxazole derivatives, process for preparation, and use thereof
US6013668A (en) * 1997-08-13 2000-01-11 Bristol-Myers Squibb Company Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino]methyl]amino]benzonitrile
RU2192412C2 (ru) * 1997-09-18 2002-11-10 Басф Акциенгезельшафт Производные бензамидоксимов, промежуточные продукты, фунгицидные средства, способ борьбы с фитопатогенными грибами
US6297239B1 (en) 1997-10-08 2001-10-02 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
AU2094700A (en) 1998-12-04 2000-06-26 Basf Aktiengesellschaft Method for producing pyrazolylbenzoyl derivatives and novel pyrazolylbenzoyl derivatives
WO2000034269A1 (en) 1998-12-09 2000-06-15 American Home Products Corporation Thiourea inhibitors of herpes viruses
US6184249B1 (en) 1998-12-18 2001-02-06 Biophysica, Inc. Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
GB9904786D0 (en) 1999-03-02 1999-04-28 Merck Sharp & Dohme Therapeutic agents
AU3931400A (en) 1999-04-02 2000-10-23 Neurogen Corporation N-benzimidazolylmethyl- and n-indolylmethyl-benzamides and their use as crf modulators
WO2001056989A2 (en) 2000-02-01 2001-08-09 Cor Therapeutics, Inc. Inhibitors of factor xa
ATE384036T1 (de) 2000-07-13 2008-02-15 Merck Patent Gmbh Chirale verbindungen i
WO2002018333A1 (en) 2000-08-31 2002-03-07 Pfizer Limited Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
GB0021670D0 (en) 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
AU2002211805A1 (en) * 2000-09-06 2002-03-22 Emisphere Technologies, Inc. Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
AU9419701A (en) 2000-10-06 2002-04-22 Tanabe Seiyaku Co Aliphatic nitrogenous five-membered ring compounds
US20050010048A1 (en) 2000-10-12 2005-01-13 Linghang Zhuang Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors
JP2004517072A (ja) 2000-11-24 2004-06-10 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー Ｃｎｓ障害の治療において有用な化合物
US6646012B2 (en) 2001-01-16 2003-11-11 Theravance, Inc. Sodium channel modulators
PL364910A1 (en) 2001-01-31 2004-12-27 Pfizer Products Inc. Ether derivatives useful as inhibitors of pde4 isozymes
DE10110438A1 (de) 2001-03-05 2002-09-19 Bayer Ag Substituierte 2-Oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
WO2002085860A1 (en) 2001-04-10 2002-10-31 Pfizer Limited Pyrazole derivatives for treating hiv
AR035700A1 (es) 2001-05-08 2004-06-23 Astrazeneca Ab Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados
DE10126434A1 (de) 2001-05-31 2002-12-05 Bayer Ag Thiochromenone
GB0202679D0 (en) 2002-02-05 2002-03-20 Glaxo Group Ltd Novel compounds
EA200901492A1 (ru) 2002-02-07 2010-08-30 Юниверсити Оф Теннесси Рисерч Фаундейшн Лечение доброкачественной гиперплазии простаты селективным модулятором рецептора андрогенов (sarm)
TW200302722A (en) 2002-02-13 2003-08-16 Astrazeneca Ab Therapeutic agents
MXPA04007870A (es) * 2002-02-15 2005-06-20 Endorech Inc Derivados de bifenilo y su uso como agentes antiandrogenicos.
AU2003214971A1 (en) 2002-02-28 2003-09-16 University Of Tennessee Research Foundation Irreversible selective androgen receptor modulators and methods of use thereof
AU2003230700A1 (en) 2002-03-26 2003-10-13 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
EP1348433A1 (en) 2002-03-28 2003-10-01 Warner-Lambert Company LLC Thiazol-2-yl-imine compounds as PDE-7 inhibitors
EP1348701A1 (en) 2002-03-28 2003-10-01 Warner-Lambert Company LLC (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
DE10218963A1 (de) * 2002-04-27 2003-11-20 Aventis Pharma Gmbh Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen
US6875438B2 (en) * 2002-04-27 2005-04-05 Aventis Pharma Deutschland Gmbh Preparations for topical administration of substances having antiandrogenic activity
US6951884B2 (en) * 2002-06-12 2005-10-04 Hoffmann-La Roche Inc. Fluorobenzamides and uses thereof
US7582230B2 (en) 2002-08-14 2009-09-01 Ciba Specialty Chemicals Corporation Liquid crystal display and colour filter with improved transparency for green light
WO2004018386A2 (en) 2002-08-26 2004-03-04 Merck & Co., Inc. Acetophenone potentiators of metabotropic glutamate receptors
MXPA05013756A (es) 2003-06-18 2006-03-08 Pfizer Prod Inc Piperazinil-ariloxi y piperazinil-heteroariloxi-n-aril-lactamas novedosas.
FI20030958A0 (fi) 2003-06-27 2003-06-27 Orion Corp Uusia yhdisteitä
JP4874965B2 (ja) 2004-07-08 2012-02-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アンドロゲン調節剤
TW200708499A (en) * 2005-06-22 2007-03-01 Warner Lambert Co Process for producing ethers

Also Published As

Publication number Publication date
AR047606A1 (es) 2006-01-25
BRPI0507670A (pt) 2007-07-17
PA8623501A1 (es) 2005-08-30
JP2007522199A (ja) 2007-08-09
KR20060116223A (ko) 2006-11-14
PE20051168A1 (es) 2006-02-18
US7576128B2 (en) 2009-08-18
AP2006003700A0 (en) 2006-08-31
ECSP066761A (es) 2006-11-16
WO2005080320A1 (en) 2005-09-01
TW200534842A (en) 2005-11-01
US20050182132A1 (en) 2005-08-18
NO20064053L (no) 2006-11-08
CR8555A (es) 2006-10-17
EA009902B1 (ru) 2008-04-28
KR100783255B1 (ko) 2007-12-06
AU2005214167A1 (en) 2005-09-01
MA28361A1 (fr) 2006-12-01
JP3997255B2 (ja) 2007-10-24
CA2554696A1 (en) 2005-09-01
EP1716110A1 (en) 2006-11-02
EA200601267A1 (ru) 2006-12-29
CA2554696C (en) 2009-06-30
IL176935A0 (en) 2006-12-10
AU2005214167B2 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
UY28746A1 (es) Moduladores de receptores de androgenos
TW200740956A (en) Organic electroluminescent devices
BR112012003792A2 (pt) gel tópico, e, uso do gel tópico.
MX2009004883A (es) Piridil sulfoximinas multi-substituidas y su uso como insecticidas.
UY31038A1 (es) Compuestos
HN2005029978A (es) Formulaciones
MX2013002058A (es) Composicion de tratamiento para cabello.
MY149705A (en) Pyridino-pyridinone derivatives, preparation therof, and therapeutic use thereof
ECSP088363A (es) Gel de testosterona y metodo de uso
DOP2006000290A (es) Moduladores de estrógenos
BRPI0907043A2 (pt) Composição, uso do composto, e, composto
GT200900031S (es) Diseño de motocicleta pequeña
CA127741S (en) Micro-excavator
UY31139A1 (es) Formas cristalinas de 3-(2r-tetrahidrofuril-metil)-2-tioxantina
DOP2005000018A (es) Moduladores de receptores de androgenos
CA127771S (en) Packaging sleeve
ECSP088533A (es) Moduladores de estrógeno
BRPI0513495A (pt) salicilato de 4-hepten-2-ila e seu uso como ingrediente de fragráncia
DOP2012000305A (es) Una combinacion antitumoral que comprende ombrabulina, un derivado de taxano y un derivado de platino
CA127772S (en) Packaging sleeve
CR10093A (es) Modulares de estrógenos
AU320425S (en) Ratchet clip
CA128623S (en) Sidechair
CA128624S (en) Sidechair
CA128621S (en) Sidechair

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160524